Ensign Peak Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $696K | Sell |
10,667
-1,550
| -13% | -$101K | ﹤0.01% | 1440 |
|
|
2025
Q1 | $818K | Hold |
12,217
| – | – | ﹤0.01% | 1361 |
|
|
2024
Q4 | $675K | Hold |
12,217
| – | – | ﹤0.01% | 1510 |
|
|
2024
Q3 | $729K | Hold |
12,217
| – | – | ﹤0.01% | 1489 |
|
|
2024
Q2 | $778K | Hold |
12,217
| – | – | ﹤0.01% | 1440 |
|
|
2024
Q1 | $845K | Sell |
12,217
-616
| -5% | -$42.6K | ﹤0.01% | 1427 |
|
|
2023
Q4 | $708K | Hold |
12,833
| – | – | ﹤0.01% | 1559 |
|
|
2023
Q3 | $745K | Hold |
12,833
| – | – | ﹤0.01% | 1413 |
|
|
2023
Q2 | $691K | Buy |
12,833
+800
| +7% | +$43.1K | ﹤0.01% | 1509 |
|
|
2023
Q1 | $478K | Buy |
12,033
+500
| +4% | +$19.9K | ﹤0.01% | 1652 |
|
|
2022
Q4 | $464K | Buy |
11,533
+4,300
| +59% | +$173K | ﹤0.01% | 1635 |
|
|
2022
Q3 | $232K | Sell |
7,233
-560
| -7% | -$18K | ﹤0.01% | 1815 |
|
|
2022
Q2 | $231K | Hold |
7,793
| – | – | ﹤0.01% | 1749 |
|
|
2022
Q1 | $219K | Hold |
7,793
| – | – | ﹤0.01% | 1852 |
|
|
2021
Q4 | $359K | Sell |
7,793
-5,390
| -41% | -$248K | ﹤0.01% | 1747 |
|
|
2021
Q3 | $433K | Hold |
13,183
| – | – | ﹤0.01% | 1650 |
|
|
2021
Q2 | $462K | Hold |
13,183
| – | – | ﹤0.01% | 1606 |
|
|
2021
Q1 | $476K | Hold |
13,183
| – | – | ﹤0.01% | 1597 |
|
|
2020
Q4 | $383K | Hold |
13,183
| – | – | ﹤0.01% | 1644 |
|
|
2020
Q3 | $372K | Hold |
13,183
| – | – | ﹤0.01% | 1594 |
|
|
2020
Q2 | $426K | Hold |
13,183
| – | – | ﹤0.01% | 1489 |
|
|
2020
Q1 | $537K | Hold |
13,183
| – | – | ﹤0.01% | 1378 |
|
|
2019
Q4 | $813K | Buy |
+13,183
| New | +$813K | ﹤0.01% | 1402 |
|